首页> 美国卫生研究院文献>Journal of Innate Immunity >In Search of a Cure for Sepsis: Taming the Monster in Critical Care Medicine
【2h】

In Search of a Cure for Sepsis: Taming the Monster in Critical Care Medicine

机译:寻找败血症的治疗方法:在重症监护医学中驯服怪物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In spite of over half a century of research, sepsis still constitutes a major problem in health care delivery. Although advances in research have significantly increased our knowledge of the pathogenesis of sepsis and resulted in better prognosis and improved survival outcome, sepsis still remains a major challenge in modern medicine with an increase in occurrence predicted and a huge socioeconomic burden. It is generally accepted that sepsis is due to an initial hyperinflammatory response. However, numerous efforts aimed at targeting the proinflammatory cytokine network have been largely unsuccessful and the search for novel potential therapeutic targets continues. Recent studies provide compelling evidence that dysregulated anti-inflammatory responses may also contribute to sepsis mortality. Our previous studies on the role of regulatory T cells and phosphoinositide 3-kinases in sepsis highlight immunological approaches that could be explored for sepsis therapy. In this article, we review the current and emerging concepts in sepsis, highlight novel potential therapeutic targets and immunological approaches for sepsis treatment and propose a biphasic treatment approach for management of the condition.
机译:尽管进行了半个多世纪的研究,败血症仍然构成医疗保健提供中的主要问题。尽管研究的进展大大增加了我们对脓毒症发病机理的认识,并带来了更好的预后和改善的生存结果,但脓毒症仍然是现代医学中的主要挑战,预计发病率会增加,社会经济负担也会增加。败血症归因于最初的过度炎症反应,这是公认的。然而,针对靶向促炎性细胞因子网络的许多努力在很大程度上没有成功,并且继续寻找新的潜在治疗靶标。最近的研究提供了令人信服的证据,即抗炎反应失调也可能导致败血症死亡率。我们先前关于调节性T细胞和磷酸肌醇3激酶在脓毒症中的作用的研究突出了可以用于脓毒症治疗的免疫学方法。在本文中,我们回顾了脓毒症的当前和新兴概念,重点介绍了脓毒症治疗的新型潜在治疗靶点和免疫学方法,并提出了双相治疗方法来管理该病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号